SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is gaining momentum as investors rally behind its unique "brandcoin" model, which emphasizes consistent community-led initiatives and real-world product expansion. The community remains highly active, frequently highlighting their diverse ecosystemranging from beverages to athletic sponsorshipsas proof of the project's long-term utility and commitment to organic growth.

Travelzoo Inc. operates as a global media commerce company which engages in the provision of information to subscribers and website users about travel, entertainment, and local deals available from various companies. Its publications and products include the Travelzoo website (travelzoo.com), the Travelzoo iPhone and Android apps, the Travelzoo Top 20 e-mail newsletter, and the Newsflash e-mail alert service. The company operates through the following geographical segments: Asia Pacific, Europe, and North America. Travelzoo was founded by Ralph Bartel on May 21, 1998 and is headquartered in New York, NY.

Travelzoo

Travelzoo is seeing increased investor interest as the community highlights the aggressive pace of the company's million-share stock buyback program, which is significantly tightening the public float. Enthusiastic market participants are closely tracking these repurchases alongside consistent insider buying, betting that the reduced share count could act as a catalyst for a sustained upward move.

Provides investment banking, securities and asset management services

Goldman Sachs Group, Inc.

Goldman Sachs is trending as investors digest its latest earnings report, which showcased resilience in trading and banking fees despite market volatility, while the stock continues to be a focal point for institutional capital flow monitoring. Community sentiment remains split between long-term bullish holders focused on its leadership in mega-IPOs and short-term traders debating whether the stock is overextended at current levels.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnival Corp (CCL) is trending as investors react to fluctuating oil prices and evolving geopolitical developments in the Middle East, which remain the primary drivers of volatility for cruise stocks. The community is actively debating the impact of these macro headwinds versus strong fundamental metrics like record bookings and recent share buyback programs, with many participants looking for a sustained breakout as the conflict landscape shifts.

Filtronic Plc engages in the provision of radio frequency technology. Its products include Morpheus II, Cerus, tower top amplifiers, Orpheus, GaN amplifiers, custom filters, switched filter banks, transceivers, transmit and receive modules, and others. It operates through the following geographical segments: United Kingdom, Europe, Americas, and Rest of the World. The company was founded by John David Rhodes in 1977 and is headquartered in Sedgefield, the United Kingdom.

Filtronic

Filtronic Plc

Filtronic is trending as investors eye its strategic role as a critical radio frequency hardware supplier for SpaceX's Starlink network. The community is actively discussing the company's long-term growth potential and recent contract wins, while navigating the challenges of accessing this OTC-listed stock.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing a surge in investor attention and sentiment following the announcement of a multi-million dollar government award and equity stake, which has officially validated its technology as a strategic national infrastructure asset. The community is actively discussing the company's competitive advantages in neutral-atom technology and sensing over sector peers, with many viewing the government backing as a catalyst for future institutional accumulation and long-term valuation growth.

Harmonic, Inc. engages in the development and sale of video delivery software, products, system solutions, and services. It operates through the Video and Broadband segments. The Video segment sells video processing and production and playout services to cable operators, satellite and telecommunications pay-TV service providers, and broadcast and media companies. The Broadband segment offers solutions to cable operators broadband access solutions and related services, including cOS software-based broadband access solution, to broadband operators globally. The company was founded in June 1988 and is headquartered in San Jose, CA.

Harmonic, Inc.

Harmonic, Inc. is capturing significant investor attention as it transitions from hardware-focused operations to a pure-play broadband software model (cOS), which community members believe creates a superior, recurring revenue profile that is not yet fully reflected in its valuation. Discussions center on the stock’s potential for multiple expansion driven by high-beta momentum, institutional accumulation, and an ongoing shift in industry cost structures that creates strong switching costs for major cable and broadband operators.

Canton Coin (CC), the network’s native utility token, was designed to reward real network usage over speculation. It aligns the success of the network with the participants who make it work, fairly rewarding app builders and app users, as well as those operating decentralized infrastructure. The result is a fundamentally different model where rewards flow to those creating value through real activity, not only miners or early investors.

Canton

Canton Network is capturing investor attention due to its role as institutional-grade infrastructure for real-world asset tokenization, supported by high-profile partnerships with global financial giants. While some participants are optimistic about its utility and adoption, the community remains divided over ongoing token unlocks and concerns regarding supply inflation.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is experiencing heightened investor interest and positive market sentiment following news of a significant premarket gain driven by promising late-stage trial results for a combination lung cancer therapy. The community is actively discussing the company's long-term pipeline potential in light of impending patent expirations for its blockbuster drug, Keytruda, while tracking competitive developments in oncology.

Themes ETF Trust - Leverage Shares 2X Long SATS Daily ETF

Leverage Shares 2x Long SATS Daily ETF

Investors are aggressively utilizing this leveraged ETF as a proxy play to gain exposure to potential SpaceX growth and connectivity developments. Community sentiment reflects a speculative 'degenerate' trading approach, with participants focused on the ticker's ability to mirror moves in the underlying asset while debating the broader risks associated with its balance sheet and volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BNB Plus Corp. Completes Historic $1.2 Million LineaDNA Order

BNB Plus Corp. (Nasdaq: BNBX) ('BNB Plus' or the 'Company'), today announced that its biopharmaceutical subsidiary, LineaRx, Inc. ('LineaRx'), has successfully completed production of its largest...

BNB Plus Corp. Announces Review of Strategic Alternatives to Maximize Shareholder Value

BNB Plus Corp. (Nasdaq: BNBX) ("BNB Plus" or the "Company"), a Nasdaq-listed digital asset treasury company focused on Binance's BNB token, today announced that its Board of Directors has authorized a formal review of strategic alternatives to maximize shareholder value and also provided an update...

Anthropic’s ‘Mythos’ Triggers Scramble Among Coinbase, Binance: Report

Equity

Large banks and tech organizations have early access to Mythos, while crypto companies still rely on older AI models and internal security technologies.

BNB Plus Corp. Announces European Patent Grant for Fundamental Technology Underlying its Linea IVT Platform

BNB Plus Corp. (Nasdaq: BNBX) ('BNBX' or the 'Company'), announced today that its biopharmaceutical subsidiary, LineaRx, Inc. ('LineaRx'), has been granted a European patent by the European Patent...

BNB Plus Corp. (BNBX) Receives Two New Orders for LineaDNA from Genetic Medicine Developers

BNB Plus Corp. (Nasdaq: BNBX) ('BNBX' or the 'Company') today announced that its biopharmaceutical subsidiary, LineaRx, Inc. ('LineaRx'), has received two new orders for LineaDNA from...

BNB Plus Corp. (BNBX) Appoints James Haft as Independent Board Director

BNB Plus Corp. (Nasdaq: BNBX) ('BNBX' or the 'Company'), today announced the appointment of James Haft as an Independent Director and member of the Boards Nominating Committee, effective as of...

BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th

BNB Plus Corp. (Nasdaq: BNBX) ('BNBX' or the 'Company'), today announced that Chief Investment Officer Patrick Horsman, CFA and Chairman of the Board Joshua Kruger will present live at the Digital...

BNB Plus Corp. (BNBX) Receives $1.2M Accelerated LineaDNA Order

BNB Plus Corp. (Nasdaq: BNBX) (BNBX or the Company), today announced that it has received a $1.2M USD order for LineaDNA, representing the largest LineaDNA order in Company history. The order is an...

BNB Plus Provides BNB Treasury and Operational Updates

BNB Plus Corp. (Nasdaq: BNBX) (BNBX or the Company), today provided a corporate update highlighting its recent strategic treasury growth, expected significant narrowing of losses at its LineaRx, Inc...

Applied DNA Rebrands as BNB Plus Corp., Elects Josh Kruger as Chairman of the Board

Applied DNA Sciences, Inc. (NASDAQ: BNBX) (the Company) today announced that it will change its name to BNB Plus Corp. (BNB Plus), reflecting the Company's commitment to delivering a yield-optimized...

BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment consists of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. The MDx Testing Services segment develops clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment is involved in the detection of DNA for industrial supply chains and security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.

BNBX
Applied Dna Sciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest BNBX News

BNBXApplied Dna Sciences Inc